These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 29509924)
1. Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection. Stefic K; Novelli S; Mahjoub N; Seng R; Molina JM; Cheneau C; Barin F; Chaix ML; Meyer L; Delaugerre C; J Infect Dis; 2018 May; 217(11):1793-1797. PubMed ID: 29509924 [TBL] [Abstract][Full Text] [Related]
2. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression. Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of acutely HIV-1-infected individuals following rapid antiretroviral therapy initiation. Girometti N; Nwokolo N; McOwan A; Whitlock G Antivir Ther; 2017; 22(1):77-80. PubMed ID: 27585954 [TBL] [Abstract][Full Text] [Related]
4. Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants. Delagreverie HM; Grude M; Lambert-Niclot S; Nere ML; Jadand C; Leport C; Raffi F; Ghislain M; Goujard C; Meyer L; Calvez V; Katlama C; Flandre P; Barin F; Delaugerre C J Antimicrob Chemother; 2019 May; 74(5):1389-1394. PubMed ID: 30690509 [TBL] [Abstract][Full Text] [Related]
5. Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection. Manak MM; Jagodzinski LL; Shutt A; Malia JA; Leos M; Ouellette J; Akapirat S; Colby DL; Phanuphak N; Eller LA; Robb ML; de Souza M; Ananworanich J; Peel SA; J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31217270 [TBL] [Abstract][Full Text] [Related]
6. Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology. de Souza MS; Pinyakorn S; Akapirat S; Pattanachaiwit S; Fletcher JL; Chomchey N; Kroon ED; Ubolyam S; Michael NL; Robb ML; Phanuphak P; Kim JH; Phanuphak N; Ananworanich J; Clin Infect Dis; 2016 Aug; 63(4):555-61. PubMed ID: 27317797 [TBL] [Abstract][Full Text] [Related]
7. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235 [TBL] [Abstract][Full Text] [Related]
8. Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy. Kassutto S; Johnston MN; Rosenberg ES Clin Infect Dis; 2005 Mar; 40(6):868-73. PubMed ID: 15736021 [TBL] [Abstract][Full Text] [Related]
9. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with sustained virologic suppression in patients receiving antiretroviral therapy in an urban HIV care clinic. Purkayastha T; Wasi F; Shuter J AIDS Patient Care STDS; 2005 Dec; 19(12):785-93. PubMed ID: 16375610 [TBL] [Abstract][Full Text] [Related]
11. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Moore RD; Keruly JC Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456 [TBL] [Abstract][Full Text] [Related]
12. Safety of monitoring antiretroviral therapy response in HIV-1 infection using CD4+ T cell count at long-term intervals. Vogler IH; Alfieri DF; Gianjacomo HDB; Almeida ERD; Reiche EMV Cad Saude Publica; 2018 Oct; 34(10):e00009618. PubMed ID: 30365742 [TBL] [Abstract][Full Text] [Related]
13. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression. Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017 [TBL] [Abstract][Full Text] [Related]
14. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity. Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595 [TBL] [Abstract][Full Text] [Related]
17. Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection. Kim JH; Mascola JR; Ratto-Kim S; VanCott TC; Loomis-Price L; Cox JH; Michael NL; Jagodzinski L; Hawkes C; Mayers D; Gilliam BL; Birx DC; Robb ML AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1021-34. PubMed ID: 11485619 [TBL] [Abstract][Full Text] [Related]
18. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764 [TBL] [Abstract][Full Text] [Related]
19. Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells. Jensen SS; Fomsgaard A; Larsen TK; Tingstedt JL; Gerstoft J; Kronborg G; Pedersen C; Karlsson I PLoS One; 2015; 10(10):e0139573. PubMed ID: 26426913 [TBL] [Abstract][Full Text] [Related]
20. The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. Markowitz M; Vaida F; Hare CB; Boden D; Mohri H; Hecht FM; Kalayjian RC; Conrad A; Mildvan D; Aberg J; Hogan C; Kilby JM; Balfour HH; Schafer K; Richman D; Little S J Infect Dis; 2010 May; 201(9):1298-302. PubMed ID: 20235838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]